author-photo

Nicole Mueller-Lenke

University of Basel

33

Papers

1432

Citations

Citation Trend

Filter By

Papers (22) Sort By

Journal Conference Others

Teriflunomide slows BVL in relapsing MS: A reanalysis of the TEMSO MRI data set using SIENA

2017 Neuroimmunology and Neuroinflammation
Show All
- Source
- Cite
- Save
Citations (47)
Teriflunomide slows BVL in relapsing MS

2017 Neuroimmunology and Neuroinflammation
Show All
- Source
- Cite
- Save
Citations (16)
Teriflunomide Slows Brain Volume Loss in Relapsing MS: A SIENA Analysis of the TEMSO MRI Dataset (P3.089)

2016 Neurology
Show All
- Source
- Cite
- Save
Citations (2)
Predicting conversion to clinically definite multiple sclerosis using machine learning on the basis of cerebral grey matter segmentations

2015 Multiple Sclerosis Journal
Show All
- Source
- Cite
- Save
Citations (0)
The effect of fingolimod on T1-hypointense lesions developed on-study and evolution of pre-existing Gd+ lesions, stratified by lesion size: A posthoc analysis of FREEDOMS study (P7.245)

2015 Neurology
Show All
- Source
- Cite
- Save
Citations (1)
Switching from natalizumab to fingolimod A randomized, placebo-controlled study in RRMS

2015 Neurology
Show All
- Source
- Cite
- Save
Citations (98)
Magnetization transfer ratio in lesions rather than normal-appearing brain relates to disability in patients with multiple sclerosis

2015 Journal of Neurology
Show All
- Source
- Cite
- Save
Citations (16)
Progression in disability and regional grey matter atrophy in relapsing-remitting multiple sclerosis.

2014 Multiple Sclerosis Journal
Show All
- Source
- Cite
- Save
Citations (27)
Classification of multiple sclerosis patients from the geometry and texture of white matter lesions

2014 F1000Research
Show All
- Source
- Cite
- Save
Citations (2)
Brain atrophy: an in-vivo measure of disease activity in multiple sclerosis

2013 Swiss Medical Weekly
Show All
- Source
- Cite
- Save
Citations (16)